Millions of Americans have dry eye disease. Individuals plagued by the discomfort, burning, irritation, photophobia, and other symptoms of dry eye disease also have blurred vision, contact lens intolerance, the inability to produce emotional tears, and an increased risk of ocular surface damage and infection. In the United States alone an estimated 2 million Sjogren's Syndrome patients have dysfunctional lacrimal glands and severe dry eye and there is no satisfactory treatment. A bioartificial lacrimal gland would greatly benefit these patients. The new field of tissue engineering has built on the interface between materials science and biocompatibility to create the possibility of developing a bioartificial lacrimal gland. Our three specific aims are: ? ? 1) To identify the optimal biomaterials for use as the substrate for the growth of rabbit lacrimal epithelial cells in a three-dimensional scaffold. ? 2) To test the physiological properties of these bioengineered tissues, including secretory functions and electrophysiological activities. ? 3) To establish strategies and data for the design and development of a bioartifical lacrimal gland as the basis for a BRG grant proposal using the RO1 funding mechanism. ? ? This work will advance our understanding of how lacrimal epithelial cells function in this artificial environment and lead to the development of an RO1 proposal. Ultimately, we envision a bioengineered lacrimal gland system, to be surgically implanted in periocular tissues that will produce sufficient tear flow to maintain the health of the ocular surface. Such a device could relieve the symptoms of millions of dry eye patients; and it could possibly make obsolete the frequent daily use of lubricant eye drops, saving patients the time and effort of medication use and saving millions of dollars annually in the purchase of lubricating eye drops. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21EY015457-02
Application #
6891292
Study Section
Special Emphasis Panel (ZRG1-DBD (10))
Program Officer
Fisher, Richard S
Project Start
2004-05-01
Project End
2007-04-30
Budget Start
2005-05-01
Budget End
2007-04-30
Support Year
2
Fiscal Year
2005
Total Cost
$194,125
Indirect Cost
Name
Doheny Eye Institute
Department
Type
DUNS #
020738787
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Selvam, Shivaram; Mircheff, Austin K; Yiu, Samuel C (2013) Diverse mediators modulate the chloride ion fluxes that drive lacrimal fluid production. Invest Ophthalmol Vis Sci 54:2927-33
Nguyen, Pho; Barte, Felise; Shinada, Shuntaro et al. (2010) Management of Corneal Graft Rejection - A Case Series Report and Review of the Literature. J Clin Exp Ophthalmol 1:
Selvam, Shivaram; Chang, Wenji V; Nakamura, Tamako et al. (2009) Microporous poly(L-lactic acid) membranes fabricated by polyethylene glycol solvent-cast/particulate leaching technique. Tissue Eng Part C Methods 15:463-74
Selvam, Shivaram; Thomas, Padmaja B; Gukasyan, Hovhannes J et al. (2007) Transepithelial bioelectrical properties of rabbit acinar cell monolayers on polyester membrane scaffolds. Am J Physiol Cell Physiol 293:C1412-9
Yiu, Samuel C; Thomas, Padmaja B; Nguyen, Pho (2007) Ocular surface reconstruction: recent advances and future outlook. Curr Opin Ophthalmol 18:509-14
Selvam, Shivaram; Thomas, Padmaja B; Trousdale, Melvin D et al. (2007) Tissue-engineered tear secretory system: functional lacrimal gland acinar cells cultured on matrix protein-coated substrata. J Biomed Mater Res B Appl Biomater 80:192-200
Selvam, Shivaram; Thomas, Padmaja B; Yiu, Samuel C (2006) Tissue engineering: current and future approaches to ocular surface reconstruction. Ocul Surf 4:120-36